Suven Life Sciences (SUVEN) — Announcement

📢 Key Event
CRISIL confirms full compliance with preferential issue proceeds utilization

💡 Investor Takeaway
Investors gain confidence in capital allocation transparency and regulatory oversight.

Suven Life Sciences disclosed a CRISIL Monitoring Agency Report for the quarter ended June 30, 2026, confirming compliance with utilization of proceeds from its Rs 85,764.02 lakh preferential issue of convertible warrants. The report verifies that all funds were deployed as per the offer document, with no deviations, delays, or material changes observed. General corporate purpose utilization remained within the 15% cap, and unutilized proceeds were parked in short-term instruments. The filing reinforces transparency in capital deployment and regulatory adherence.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUVEN ✨ Ask AI About This

About Suven Life Sciences Limited (SUVEN)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹11,087.76 Cr ROE: -80.9% ROCE: -80.7%

View full SUVEN stock details →

📡 Get AI alerts when SUVEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUVEN — Free

💡 Ask AI about this filing

"How does the utilization rate compare to previous quarters?" "What is the expected timeline for full deployment of remaining funds?" "How does this affect Suven's valuation metrics?"

Ask AI Free →

📊 More SUVEN filings

See all SUVEN filings →

🔥 Also filed on 11 August 2026

ULTRACEMCO UltraTech Cement Limited Announcement SUDEEPPHRM Sudeep Pharma Limited Financial Results SUTLEJTEX Sutlej Textiles and Industries Limited Financial Results RBZJEWEL RBZ Jewellers Limited Financial Results TATVA Tatva Chintan Pharma Chem Limited Corporate Action AETHER Aether Industries Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUVEN files new disclosures

Track SUVEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUVEN — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd